During gaseous exchange the lungs are exposed to a vast variety of pathogens, allergens, and innocuous particles. A feature of the lung immune response to lung-tropic aerosol-transmitted bacteria such as Mycobacterium tuberculosis ( Mtb ) is a balanced immune response that serves to restrict pathogen growth while not leading to host-mediated collateral damage of the delicate lung tissues. One immune-limiting mechanism is the inhibitory and anti-inflammatory cytokine interleukin (IL)-10. IL-10 is made by many hematopoietic cells and a major role is to suppress macrophage and dendritic cell (DC) functions, which are required for the capture, control, and initiation of immune responses to pathogens such as Mtb . Here, we review the role of IL-10 on bacterial control during the course of Mtb infection, from early innate to adaptive immune responses. We propose that IL-10 is linked with the ability of Mtb to evade immune responses and mediate long-term infections in the lung.
Tuberculosis (TB) is predominantly a disease of the lungs; however, dissemination of the pathogen to other disease sites does occur but depends on productive infection of the lungs. The current figures for 2009 (see ref. 1) show that TB is once more on the increase; globally, there is a large burden of disease with ~ 9.4 million new cases (of which 1.1 million cases were in human immunodeficiency virus-positive individuals) and 1.7 million deaths annually (of which 0.4 million were in human immunodeficiency virus-positive individuals). Following infection, alveolar macrophages phagocytose the pathogen but are unable to efficiently kill all the invading Mtb bacilli, giving rise to a host -pathogen equilibrium where a small percentage of bacilli survive the antimicrobial cascade elicited by host immune cells. The infection is controlled in part by walling it off from the rest of the uninfected lung in radiographically distinct foci known as granulomas; Mtb persists within these foci in the unfused phagosomes of macrophages, giving rise to a latent infection. 2, 3 Recent evidence from the Mycobacterium marinum model of TB infection suggests that recruitment of macrophages into a nascent granuloma is a mechanism used by mycobacteria to facilitate intercellular spread. 4 -6 As such, TB granulomas might be a trade-off that benefits both host and pathogen. 2 On average, a vast majority of individuals exposed to Mtb mount an efficient cell-mediated immune response culminating in a so-called latent infection with no clinical signs of disease. However, the remaining ~ 5 -10 % of individuals will progress to active disease as demonstrated by culturable bacilli from the sputum and the development of clinical symptoms. 1 Although a number of mechanisms have been described for the development of a protective immune response that restricts and controls infection and thus prevents progression to active disease, the reasons underlying active disease progression remain poorly understood. Based on its properties it is likely that interleukin-10 (IL-10) may contri bute to TB pathogenesis. Here, we outline the key elements in the immune response to Mtb with emphasis on stages where IL-10 can limit or subvert the protective immune responses mounted by the host following infection (summarized in Figure 1 ).
PROTECTIVE FACTORS IN THE IMMUNE RESPONSE TO Mtb : EVIDENCE FROM MOUSE AND MONKEY MODELS, AND HUMANS
The essential requirement for the IL-12 / T helper type 1 cell (T H 1) axis in the control of mycobacterial infections has been observed in patients exhibiting MSMD (Mendelian susceptibility to mycobacterial diseases; reviewed in ref. 7) . Mutations in genes encoding the IL-12 receptor render individuals extremely susceptible to intracellular pathogens such as atypical mycobacteria 8 -10 and pulmonary TB (PTB). 11 Similarly, mutations in the interferon-receptor 1 (IFN-R1) and its key downstream signaling molecule STAT1 (signal transducer and activator of
The role of IL-10 in immune regulation during M. tuberculosis infection REVIEW transcription 1) also render individuals extremely susceptible to PTB, 12 Bacille Calmette-Gu é rin (BCG), 13, 14 and environmental mycobacteria. 15 -18 CD4 + T cells are essential in the immune response to Mtb as reported in humans co-infected with human immunodeficiency virus / Mtb , 19 -21 and as further supported by non-human primate studies 22 and mouse models, 23 -25 whereby in their absence, the host rapidly succumbs to infection. The importance of tumor necrosis factor-(TNF-) in the control of human TB was realized when rheumatoid arthritis patients latently infected with Mtb received anti-TNF therapy, which led to TB reactivation. 26 In line with the observations in humans, the importance of TNF-in preventing reactivation of latent TB has also been shown in non-human primate studies 27 and mouse models. 28, 29 The findings in human genetic studies highlighting the importance of IFN-and IL-12 have also been demonstrated in mouse models of Mtb . Mice deficient in IFN-, 30, 31 [32] [33] [34] or TNF- 35, 36 succumb early to Mtb infection with high bacterial loads. The IL-12 / CD4 / IFN / IFN R / STAT1 axis is crucial for the IFN-activation of infected macrophages to facilitate bacterial killing; however, the overall antimycobacterial mechanisms in humans remain unknown. In this review we first outline the basic functions of IL-10, which collectively can result in negative regulation of such factors, which have been demonstrated to be protective against Mtb infection.
IL-10: BACKGROUND
More than 20 years ago, the cytokine IL-10 was identified as a " cytokine synthesis inhibitory factor, " a product of T H 2 clones following protein or antigen stimulation, that blocked cytokine production from T H 1 clones. 37 IL-10 achieved this effect by inhibiting the ability of myeloid cells such as macrophages and dendritic cells (DCs) to activate T H 1 cells. 38 We now know that IL-10 is not just made by Th2 cells, but can be produced by most if not all CD4 + T-cell subsets, including T H 1 and T H 17 cells, B cells, neutrophils, macrophages, and some DC subsets. 39 Regulatory T cells (Tregs), in the context of infectious disease, also serve as a major source of immunoregulatory IL-10 and, depending on their developmental origin, may come in several forms (reviewed in refs. 39, 40, and 41). Thymic IL-10 signals through a receptor complex consisting of two subunits: IL10R1 , induced on stimulated hematopoietic cells, and the IL10R2 , constitutively expressed on most cells and tissues. 38 These receptor subunits transduce signals through the Janus kinase (Jak) -STAT pathway via Jak1 in the mouse and Jak1 and tyrosine kinase 2 (Tyk2) in humans, culminating in tyrosine phosphorylation and activation of STAT3, as well as STAT1, and in nonmacrophage cells, STAT5 (reviewed in refs. 38 and 39). However, the genetic and biochemical evidence from both mouse and human systems implicates STAT3 as the sole STAT required to generate the IL-10 inhibitory signal. 47 -49 Induction of IL-10 in cells of the innate and adaptive immune response IL-10 is produced by both myeloid cells and T cells. In myeloid cells, IL-10 is induced following Toll-like receptor (TLR) ligation in response to a plethora of pathogen products. The magnitude of IL-10 induction within different myeloid cell types has been linked to the relative strength of extracellular signal-related kinases 1 and 2 (ERK1 / 2) activation. 50 For example, macrophages activate high amounts of ERK in comparison with myeloid DCs, which activate intermediate amounts; this is in contrast to plasmacytoid DCs that have low ERK activation and ultimately cannot make IL-10. However, cytokine production by plasmacytoid DCs in response to TLR ligation can be significantly inhibited when exogenous IL-10 is added to cell cultures. 51 The induction of IL-10 in myeloid cells in response to TLR ligands requires the signaling adaptor molecules MyD88 (myeloid differentiation primary response gene (88)), Toll-IL-1 receptor (TIR) domain-containg adaptor inducing IFN-β (TIR-containing adaptor molecule-1), and a plethora of indirect pathways mediated by autocrine / paracrine factors. 39,51 -53 MyD88 is crucial in the control of Mtb infection; 54, 55 however, studies in mice focusing specifically on TLR-associated protection suggest that TLR / MyD88 signaling pathways may not be essential (reviewed in ref. 56 ) and instead that IL-1 / IL-1R1 / MyD88-dependent pathways function to control Mtb infection. 57 These findings reflect the overall complexity of the signaling cascades involved.
In addition to IL-10 induction by TLR-dependent stimuli, IL-10 can also be induced from innate cells such as DCs via TLR-independent stimuli including C-type lectin receptors, via the spleen tyrosine kinase-dependent pathway. 58 IL-10 can be induced in neutrophils in response to Mtb through CARD9 (caspase recruitment domain family, member 9) 59 or to BCG by activation of spleen tyrosine kinase, leading to phosphorylation of p38 mitogen-activated protein kinases and serine / threonine Akt kinases. 60 Alternatively, stimulation through CLEC4M (DC-SIGN) via activation of RAF1 61 also leads to IL-10 production in response to Mtb . Furthermore, C-type lectin receptor stimulation in the presence of Fc R ligation 62 or CD40 triggering 63 can further potentiate the production of IL-10.
IL-10 production by CD4 + T cells after T H differentiation requires sustained ERK1 / 2 phosphorylation, 64 where IL-10 expression is accompanied by the hallmark cytokines for the respective Th subsets: T H 1 -IFN-, T H 2 -IL-4, and T H 17 -IL-17 (reviewed in ref. 39 ). IL-10 can also be produced by other immune cells such as CD8 + T cells, B cells, eosinophils, and mast cells; however, the pathways required for IL-10 induction in these cells are not fully known.
IL-10: REGULATION OF THE ANTIGEN-PRESENTING CELLS AND ITS EFFECTS ON THE PROTECTIVE T H 1 RESPONSE
IL-10 inhibits the protective immune response to pathogens by blocking the production of proinflammatory cytokines, such as TNF-and the T H 1-polarizing cytokine IL-12, by directly acting on antigen-presenting cells such as macrophages and DCs. 65, 66 IL-10 can also inhibit phagocytosis and microbial killing through limiting the production of reactive oxygen and nitrogen intermediates in response to IFN-, 38, 67, 68 all of which are pivotal for mediating immunity to intracellular pathogens. Recent studies from several groups also suggest that the effects of IL-10 are not solely restricted to direct effects on the antigenpresenting cells as IL-10 can also enhance the differentiation of IL-10-producing inducible Tregs during experimental autoimmune encephalomyelitis. 69 In addition, IL-10 from CD11b + myeloid cells is also required for maintaining FoxP3 expression and Treg function, 70 possibly via direct interactions through the IL-10-receptor (IL-10R) expressed on the Treg itself. These reports propose positive feedback loops for the induction of IL-10 by distinct Treg populations and thus provide an additional level of immune regulation. However, it is important to note that the direct effects of IL-10 on T cells remain unclear and further studies using T cell-specific deletion of the Il10ra gene will be necessary to definitively establish the significance of non-myeloid IL-10 signaling 71 in regulation of the immune response.
IL-10 IN THE CONTEXT OF INFECTIOUS DISEASES
The importance of IL-10 in controlling inflammatory responses was originally suggested by early observations in IL-10-deficient ( Il10 − / − ) mice that develop unrelenting colitis 72 in response to gut flora. 73 In the context of infectious disease, studies using Listeria monocytogenes , 74 -76 lymphocytic choriomeningitis virus, 77, 78 Leishmania major , 79, 80 and Leishmania donovani 81 have all reported an increase in pathogen clearance in the absence of IL-10, in addition to a range of other experimental REVIEW infections. 82 During L. major infection, although the absence of IL-10 enhanced pathogen clearance, mice displayed a loss of immunity to re-infection, 80 suggesting that IL-10 does limit pathogen clearance, but has a key role in the maintenance of effector memory populations via a mechanism that remains unknown. In contrast, during infection with Toxoplasma gondii , 83 -85 Trypanosoma cruzi , 86 and Plasmodium chabaudi chabaudi , 87 experimental infection in Il10 − / − mice causes excessive and often lethal inflammatory responses. These studies, on Il10 − / − mice during infection with diverse pathogens, highlight that IL-10 function may result in distinct outcomes during different infections. In some cases, too much IL-10 at one end of the scale may overcontrol otherwise protective T-cell responses, leading to chronic infection, and at the other end, too little or no IL-10 may tend toward fatal host-mediated pathology. Thus, IL-10 manages a delicate balance between suppressing and activating host responses to virtually all pathogens. Upon aerosol exposure with Mtb , the first cells to be exposed to the pathogen include alveolar macrophages and lung DCs, both of which readily phagocytose Mtb and become activated, producing the cytokines TNF-and IL-12 to promote host antimicrobial mechanisms, in addition to induction of IL-10, which may inhibit them. 88 -91 Once phagocytosed by macrophages, the Mtb bacillus survives and persists by inhibition of phagosome -lysosome fusion, 92 and in doing this Mtb can still gain access to essential nutrients such as iron via the early endocytic pathway. 93, 94 The production of IL-10 following phagocytosis of Mtb by macrophages may occur as a natural anti microbial response by the host, or may be induced by the bacteria as an evasion mechanism (discussed below). IL-10 blocks phagosome maturation by a STAT3-dependent, p38-independent mechanism, which facilitates Mtb survival and outgrowth. 95 One key mechanism of Mtb killing is mediated by IFN-activation of macrophages, leading to enhanced production of reactive oxygen and nitrogen intermediates, 96 -99 which can be inhi bited by IL-10, 38, 67, 68 and occurs by a MyD88-dependent mechanism. 100 In addition to antagonizing the effects of IFN-on macrophage activation, IL-10 produced during phagocytosis may also function to block antigen presentation via downregulation of major histocompatibility complex molecules. 38 DCs can be infected with Mtb , 103, 104 but are unable to kill phagocytosed bacilli. 90, 105 Instead, the primary function of DCs after mycobacterial infection is to process antigen and to migrate to draining lymph nodes. This process has in part been shown to be dependent on IL-12p40 106 and can be inhibited by IL-10, 106,107 inadvertently leading to disease progression. DCs drive T-cell differentiation, 108, 109 and facilitate recruitment of Th1 cells back to the lung. Inhibitory effects of IL-10 on the production of C-X-C motif chemokine 10 (CXCL10; IFN--induced protein 10 (IP-10)) during Mtb infection suggest that IL-10 may limit recruitment of T H 1 cells to the lungs of infected mice 110 (summarized in Figure 1 ) . Indeed, the absence of DCs during early Mtb infection leads to an impaired T H 1 response with increased bacterial loads. 111 
Evidence for IL-10 as a limiting factor in the immune response to Mtb in humans
In human TB studies, IL-10 has been shown to be elevated in the lungs 112 -114 and serum of active PTB patients. 115 Studies on peripheral blood mononuclear cells obtained from PTB patients have shown that neutralization of endogenous IL-10 increased T-cell proliferation 116 and IFN-production. 116, 117 Furthermore, studies on peripheral blood mononuclear cells obtained from patients with anergic TB (individuals confirmed as having PTB but with no dermal reactivity to purified protein derivative (PPD)) have demonstrated that neutralization of endogenous IL-10 enhanced proliferative responses to PPD. 118 Collectively, these studies 117, 118 concluded that IL-10 was functioning to limit the immune response to Mtb and may contribute to TB pathogenesis. When looking specifically at lung samples from PTB patients, IL-10 and another immunosuppressive factor, TGF-, were reported to be elevated in bronchoalveolar lavage (BAL) fluid, which comprised predominantly of macrophages and neutrophils. 114, 119 A study by the same group also observed enhanced levels of IL-10 in the sputum of PTB patients, which positively correlated with the increased levels of CFP32, an Mtb antigen, suggesting an association between IL-10 and a failure to control Mtb infection. 113 Interestingly, both IL-10 and TGF-can inhibit CD4 + T-cell proliferation and IFN-production in peripheral blood mononuclear cells from healthy PPD + patients, 120 most likely through inhibition of antigen-presenting cell function.
With these effects of IL-10 in mind, one potential source could be CD4 + T cells, as demonstrated by Gerosa et al. , 121 who reported the presence of CD4 + T cells producing both IFN-and IL-10 in the Mtb antigen-specific T-cell clones isolated from BAL of active TB patients. These findings in the BAL were in contrast to CD4 + T cells derived from the peripheral blood. 121 To compliment these conclusions in human BAL that CD4 + T cells are a source of IL-10 during infection, transgenic mice that overexpress IL-10 in the T-cell compartment have enhanced susceptibility to BCG 101 and Mtb 122 because of an inability to control infection leading to exacerbated disease. In keeping with a role for IL-10 in TB pathogenesis, in a human case -control study in The Gambia, variations in allele 2 of SLC11A1 (Nramp1) were identified along with an association with enhanced production of IL-10 by monocytes and innate cells in response to lipopolysaccharide. Such variations correlated with increased susceptibility to PTB. 123 In line with these observations in human populations, 123 infection of mice, where the macrophage compartment specifically overexpresses IL-10, leads to a significant reduction in reactive nitrogen intermediates, an increase in arginase-1, and overall reduced macrophage function. 102 These findings are in keeping with recent studies showing that arginase-1 is specifically regulated by a STAT3-dependent pathway by autocrine / paracrine TLR-induced IL-10, IL-6, and granulocyte colony-stimulating factor. 124 These cytokines are found in abundance during mycobacterial infection and can collectively control arginase-1, and therefore nitric oxide amounts that would kill mycobacteria. Irrespective of the cellular source of IL-10 in studies using IL-10 transgenic mice, REVIEW the outcome culminates in a pronounced inability to control bacterial growth, leading to mice succumbing earlier to disease during infection. These events occur despite the fact that the host has an intact T-cell IFN-response. 101, 102 These studies highlight both innate and adaptive sources of IL-10 during Mtb infection, making it plausible that the cellular source of IL-10 is dynamic and is likely to depend on the stage of infection and anatomical location of the disease.
Human genetic studies examining the key polymorphisms in the IL-10 gene, more specifically loci 1,082, 819, and 592, and susceptibility to TB, have proved inconclusive with mixed outcomes that appear to be dependent on geographical location. 125 -134 Furthermore, using meta-analysis, Pacheco et al. 135 analyzed the IL-10 polymorphism data from published studies 125,127 -133 and showed a trend toward an association between polymorphisms in the IL-10 gene and increased susceptibility; however, it did not reach statistical significance. 135 In conclusion, the human studies of TB infection suggest that during chronic infection, endogenous IL-10 from both innate and adaptive sources may inhibit protective T H 1 responses via indirect action on macrophages or DCs, and although functioning to limit immunopathology may result in chronic infection. However, these studies could not address the relationship between IL-10 and its suppressive effect on pathogen eradication.
THE ROLE OF IL-10 IN LIMITING THE IMMUNE RESPONSE IN MOUSE MODELS OF NONTUBERCULAR MYCOBACTERIAL INFECTIONS
Studies addressing the role of IL-10 during mycobacterial infections such as Mycobacterium avium 136 -138 and BCG 139 -141 in Il10 − / − mice show enhanced protection while showing no signs of aberrant host-mediated pathology, which perhaps reflects the slow disease progression of these mycobacterial pathogens. Furthermore, in the context of infectious disease, antagonists of IL-10 may act as adjuvants during vaccination as has been shown with L. major 142 -144 or M. avium , 145 which significantly improves disease outcome (reviewed in ref. 146 ).
THE ROLE OF IL-10 IN LIMITING THE IMMUNE RESPONSE IN MOUSE MODELS OF Mtb INFECTION
Human TB studies suggest a potential role for IL-10 in TB pathogenesis; however, specific aspects of TB biology, for example bacterial killing, cannot be readily addressed in vivo in humans. Experimental animal models, such as the mouse, represent a reproducible in vivo manipulative system and serve as a crucial aid, allowing us to bridge these limitations and to gain further insight into complex human diseases like TB. Initially, the role of IL-10 during murine Mtb infection appeared controversial, with studies focusing predominantly on Il10 − / − mice on the so-called " resistant " genetic backgrounds such as the C57Bl / 6. Some groups have reported that Il10 − / − mice have comparable lung bacterial loads following aerosol Mtb infection when compared with wild-type mice. 147 -149 Interestingly, the levels of IFN-observed in the lungs of Il10 − / − mice from these studies were greatly enhanced early during infection when compared with wild-type mice, although in these studies this failed to translate into any effect on bacterial control. 147, 149 One study went on to suggest that the lack of effect on bacterial load in C57BL / 6 Il10 − / − mice was in fact because of compensatory immune suppression by TGF-, 149, 150 and that Il10 − / − animals succumbed earlier than wild-type controls during chronic stages of infection because of host-mediated pathology. 149 In contrast, others have reported that in the absence of IL-10, mice display enhanced resistance to aerosol Mtb infection with reduced bacterial loads. 110, 137, 151 Accompanying this decrease in bacterial load were elevated production of IFN- 110, 137, 152 and earlier enhanced levels of cytokines associated with granuloma formation (granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, TNF-, and IL-17A), and T-cell recruitment (CXCL10 and IL-17A) in the lungs and serum. 110 In line with the human polymorphism studies, which highlight genetic variability in the Il10 locus between different geographic populations and increased susceptibility to TB, similar findings have been observed between genetically different strains of mice. Mtb infection in " susceptible " mouse strains such as the CBA / J, which has a greater propensity to produce IL-10 relative to other inbred mouse strains, leads to decreased IL-12p40, TNF-, and IFN-, and exacerbated bacterial burdens. 122 These observations are in contrast to " resistant " C57Bl / 6 mice, which produce lower amounts relative to other strains. 122 To counteract the enhanced levels of IL-10 in CBA / J mice, blockade of IL-10R signaling during chronic infection with an IL-10R blocking monoclonal antibody (anti-IL-10R) enhances T-cell recruitment and T cell-derived IFN-, leading to enhanced survival associated with reduced bacterial burdens. 151 Furthermore, our group has also recently shown that Mtb infection of Il10 − / − mice on both the C57Bl / 6 and BALB / c backgrounds, as well as in CBA / J mice treated throughout infection with anti-IL-10R monoclonal antibody, leads to increased reductions in bacterial load in both the lungs and spleen when compared with their respective control counterparts. 110 The differences between these studies may be linked to the sources of mice, their biological-specific pathogen-free status, including gut flora, or differences between laboratory strains of Mtb used. 153 These factors may translate into phenotypic differences during controlled experimental infections.
IMMUNE SUBVERSION BY Mtb THROUGH INDUCTION OF IL-10
The induction of IL-10 during Mtb infection may not just be a response initiated by the host in order to avoid or limit host-mediated pathologies. Evidence from viral infections such as Epstein -Barr virus suggest that during infection IL-10 can indeed be induced to blunt the immune response and allow the establishment of a chronic infection (reviewed in ref. 38 ). Similar to viruses, these observations have also been noted during Mtb infection. Two such examples include the Mtb strains " HN878 " and " CH. " The Mtb strain HN878, a member of the W-Beijing lineage, was originally isolated in Houston (USA) after causing 60 cases of TB and was responsible for at least three clusters of disease between 1995 and 1998. HN878 has a hypervirulent phenotype in mice, 154 which is associated with REVIEW the presence of a phenolic glycolipid, 155 normally absent in other clinical Mtb isolates (CDC1551) or laboratory strains (H37Rv). Furthermore, the hypervirulent phenotype of HN878 has been strongly associated with the induction of type I IFNs 154, 156 as well as the early induction of IL-10 by a CD4 + CD25 + FoxP3 + CD223 + regulatory T-cell population, 157 and enhanced arginase-1 expression. 124 The Mtb strain CH was originally isolated in 2001 following a school-associated outbreak in Leicester (UK) and its virulence was associated with a deletion affecting the Mtb gene Rv1519 . 158 Infection of human monocytederived macrophages with the CH strain (when compared with the well-documented Mtb strains CDC1551 and H37Rv) led to induction of IL-10, which correlated with reduced production of IL-12p40. Complementation of the CH strain with Rv1519 reversed this capacity to specifically induce IL-10. These studies clearly demonstrate another virulence mechanism whereby Mtb can exploit host-derived factors in order to establish chronic infection through subversion of the protective host response, a mechanism that, to date, warrants further investigation.
CONCLUDING REMARKS AND FUTURE ISSUES
We hypothesize that IL-10 is functioning largely to limit pathogen clearance during the early immune response to Mtb by its inhibitory effects on macrophage activation and DC function. One such pathway includes the inhibition of phagosome -lysosome fusion. 95 The induction of IL-10 may differ between Mtb isolates, and the cellular source of IL-10 during infection appears to be dynamic, probably depending on the stage of infection, the anatomical location of the disease and the specific pathogen. For example, the early sources of IL-10 during infection are myeloid cells such as macrophages. However, as the adaptive cell-mediated response becomes apparent, the T cells become a major source of IL-10 production. To date, there is limited information on the specific cellular sources of IL-10 during the course of Mtb infection, an area that we feel warrants further investigation. Identifying the cellular sources of IL-10 following vaccination, and in response to Mtb infection, may provide us with immunotherapeutic targets in order to fight TB. Once chronic infection has been established and levels of IL-10 are still detectable, it would seem plausible to suggest that IL-10 now serves to limit fatal host-mediated immunopathology by blunting overexuberant effector responses. In this context, it would appear that successful mycobacterial strains have harnessed the natural suppressive effects of IL-10 to create a niche within nonoptimally activated macrophages. In this scenario, the host also benefits by escaping damaging immunopathology. However, to date, there is limited published evidence supporting a role for IL-10 in blocking host-mediated immuno pathology during chronic Mtb infection. 149 In contrast to Higgins et al. , 149 our own group have found no signs of lung immunopathology (including weight loss) in Il10 − / − mice during Mtb infection (P.S. Redford and A. O ' Garra, unpublished data) despite observations that Il10 − / − mice have significantly enhanced levels of IFN-and IL-17 early during infection. 110 In the context of IL-17-driven immunopathology, the balance between IFN-and IL-17 production during the course of Mtb infection is likely to be a key determinant in the immunopathological outcome (reviewed in ref. 159) . Potentially, if the balance shifts in favor of IL-17, this may facilitate host-mediated pathology by the recruitment of neutrophils that may potentially hamper protective immune responses as observed in susceptible mouse strains that exhibit enhanced lung neutrophila and high mortality 160, 161 or in Mtb-infected mice given repeated BCG vaccination. 162 With the potential for IL-17 to drive protective immune responses as well as contribute to immunopathology, its regulation by IFN-and / or IL-10 during Mtb infection has received limited attention to date. However, one study from our group has shown that IL-10 may dampen IL-17A production during Mtb infection. 110 Furthermore, the increased IL-17A observed in Il10 − / − mice was not responsible for the enhanced cellular responses or the enhanced protection observed 110 and did not lead to immunopathology.
In contrast, the role of IL-17 in bacterial control during primary immune responses to Mtb is less clear, yielding conflicting reports. 110,163 -165 The induction of IL-10 during vaccination or chemotherapy could skew the priming or clearance of Mtb and in its absence may yield a better prognosis for the host, and may provide a strategy to help eliminate infection with multidrug-resistant Mtb. For example, during vaccination leading to enhanced protection to subsequent Mtb infection, IL-23 facilitates the recruitment of IL-17-producing antigen-specific cells into the lungs, which in turn drives the influx of T H 1 cells 166 (reviewed in ref. 167 ). IL-10 could be functioning to regulate the sources of IL-23 during the early stages of vaccination or in response to Mtb challenge. Future strategies for combating TB should therefore look toward the role of IL-10 in these scenarios and how in the absence of IL-10 the immune response is changed, as has been shown in models of Leishmania , 142 -144 M. avium, 145 and lymphocytic choriomeningitis virus 78 (reviewed in ref. 146) .
In summary, the protective immune response to Mtb infection, which prevents progression to active disease, may be attributed to the finite balance between proinflammatory and immunoregulatory mechanisms. IL-10 represents one such regulatory mechanism that Mtb could be exploiting in order to establish a chronic infection and may therefore serve as an important target for the design of novel immune therapies.
